Evidence map›Paper›PMID 36026526›Full record

ArticleThe American journal of clinical nutrition2022

The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.

Marie S A Palmnäs-Bédard, Giuseppina Costabile, Claudia Vetrani, Sebastian Åberg, Yommine Hjalmarsson, Johan Dicksved, Gabriele Riccardi, Rikard Landberg

Open access · bronzeAbstract readScoping Review
In one paragraph

Article in The American journal of clinical nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Functional PET imaging of gut microbiota with [European journal of nuclear medicine and molecular imaging · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Kimchi ProbioticJournal of microbiology and biotechnology · 2026
    Article
  17. [Association between wearable-derived physical activity patterns and gut microbiota in older adults].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Article
  18. Article
  19. Article
  20. GLP-1 agonists and the gut microbiome: A bidirectional relationship.British journal of clinical pharmacology · 2026
    Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Marie S A Palmnäs-BédardDepartment of Biology and Biological Engineering, Division of Food and Nutrition Science, Chalmers University of Technology, Gothenburg, Sweden.ORCID 0000-0002-3906-7638
Giuseppina CostabileDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Claudia VetraniDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Sebastian ÅbergDepartment of Biology and Biological Engineering, Division of Food and Nutrition Science, Chalmers University of Technology, Gothenburg, Sweden.
Yommine HjalmarssonDepartment of Communication and Learning in Science, Chalmers University of Technology, Gothenburg, Sweden.
Johan DicksvedDepartment of Animal Nutrition and Management, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Gabriele RiccardiDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Rikard LandbergDepartment of Biology and Biological Engineering, Division of Food and Nutrition Science, Chalmers University of Technology, Gothenburg, Sweden.ORCID 0000-0002-6399-7608
Chalmers University of Technology · SEUniversity of Naples Federico II · ITSwedish University of Agricultural Sciences · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota plays a fundamental role in human nutrition and metabolism and may have direct implications for type 2 diabetes and associated preconditions. An improved understanding of relations between human gut microbiota and glucose metabolism could lead to novel opportunities for type 2 diabetes prevention, but human observational studies reporting on such findings have not been extensively reviewed. Here, we review the literature on associations between gut microbiota and markers and stages of glucose dysregulation and insulin resistance in healthy adults and in adults with metabolic disease and risk factors. We present the current evidence for identified key bacteria and their potential roles in glucose metabolism independent of overweight, obesity, and metabolic drugs. We provide support for SCFAs mediating such effects and discuss the role of diet, as well as metabolites derived from diet and gut microbiota interactions. From 5983 initially identified PubMed records, 45 original studies were eligible and reviewed. α Diversity and 45 bacterial taxa were associated with selected outcomes. Six taxa were most frequently associated with glucose metabolism: Akkermansia muciniphila, Bifidobacterium longum, Clostridium leptum group, Faecalibacterium prausnitzii, and Faecalibacterium (inversely associated) and Dorea (directly associated). For Dorea and A. muciniphila, associations were independent of metabolic drugs and body measures. For A. muciniphila and F. prausnitzii, limited evidence supported SCFA mediation of potential effects on glucose metabolism. We conclude that observational studies applying metagenomics sequencing to identify species-level relations are warranted, as are studies accounting for confounding factors and investigating SCFA and postprandial glucose metabolism. Such advances in the field will, together with mechanistic and prospective studies and investigations into diet-gut microbiota interactions, have the potential to bring critical insight into roles of gut microbiota and microbial metabolites in human glucose metabolism and to contribute toward the development of novel prevention strategies for type 2 diabetes, including precision nutrition.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeAdultFatty Acids, VolatileGlucoseHumansProspective StudiesVerrucomicrobiaFatty Acids, VolatileGlucosediet–gut microbiota interactionsglucose metabolismgut microbiotahumansinsulin resistancemicrobial metabolitesprecision nutritionprediabetesshort-chain fatty acidstype 2 diabetes prevention

Identifiers

PMID36026526
PMCPMC9535511
OpenAlexW4293150412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.